Epidemiology, symptomatology and treatment of patients with myasthenia gravis in an Australian hospital

被引:3
|
作者
Li, Vivien [1 ]
Jasinarachchi, Mahi [1 ]
Butler, Ernest [1 ,2 ]
机构
[1] Frankston Hosp, Peninsula Hlth, Dept Neurol, Melbourne, Vic, Australia
[2] Natl Hosp Neurol & Neurosurg, Mailbox 71, London WC1N 3BG, England
关键词
myasthenia gravis; epidemiology; treatment; intravenous immunoglobulin; thymectomy; IMMUNOGLOBULIN;
D O I
10.1111/imj.14662
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Myasthenia gravis (MG) is a disorder affecting neuromuscular transmission with heterogeneous manifestations and treatments. This study describes clinical features and management of MG patients at a metropolitan hospital in Australia. Overall findings were consistent with previously published data. However, frequency of intravenous immuno-globulin use was higher, reasons for which are explored. Management is best conducted through specialist clinics with necessary expertise and standardised treatment protocols.
引用
收藏
页码:1537 / 1540
页数:5
相关论文
共 50 条
  • [1] Myasthenia Gravis Treatment Updates
    CortOs-Vicente, Elena
    Gallardo, Eduard
    Elvarez-Velasco, Rodrigo
    Illa, Isabel
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2020, 22 (08)
  • [2] Treatment of juvenile myasthenia gravis
    Arroyo, Hugo A.
    MEDICINA-BUENOS AIRES, 2019, 79 : 71 - 76
  • [3] The epidemiology of myasthenia gravis
    Phillips, LH
    SEMINARS IN NEUROLOGY, 2004, 24 (01) : 17 - 20
  • [4] Clinical features and impact of myasthenia gravis disease in Australian patients
    Blum, Stefan
    Lee, David
    Gillis, David
    McEniery, David F.
    Reddel, Stephen
    McCombe, Pamela
    JOURNAL OF CLINICAL NEUROSCIENCE, 2015, 22 (07) : 1164 - 1169
  • [5] Treatment of Myasthenia Gravis
    Vikas Kumar
    Henry J. Kaminski
    Current Neurology and Neuroscience Reports, 2011, 11 : 89 - 96
  • [6] Treatment of Myasthenia Gravis
    Kumar, Vikas
    Kaminski, Henry J.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2011, 11 (01) : 89 - 96
  • [7] Treatment of Myasthenia Gravis
    Farmakidis, Constantine
    Pasnoor, Mamatha
    Dimachkie, Mazen M.
    Barohn, Richard J.
    NEUROLOGIC CLINICS, 2018, 36 (02) : 311 - +
  • [8] IVIG and PLEX in the treatment of myasthenia gravis
    Bril, Vera
    Barnett-Tapia, Carolina
    Barth, David
    Katzberg, Hans D.
    MYASTHENIA GRAVIS AND RELATED DISORDERS II, 2012, 1275 : 1 - 6
  • [9] The Epidemiology of Myasthenia Gravis in Korea
    Lee, Hyung Seok
    Lee, Hye Sun
    Shin, Ha Young
    Choi, Young-Chul
    Kim, Seung Min
    YONSEI MEDICAL JOURNAL, 2016, 57 (02) : 419 - 425
  • [10] Treatment of MuSK-Associated Myasthenia Gravis
    El-Salem, Khalid
    Yassin, Ahmed
    Al-Hayk, Kefah
    Yahya, Salma
    Al-Shorafat, Duha
    Dahbour, Said S.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2014, 16 (04)